Ledger.Open graph →
SEC Form D · filed January 3, 2019

Vyome Therapeutics Inc

Offering
$11.3M
Sold
$11.3M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DELHI, K7
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Venkateswarlu Nelabhotla · Delhi, K7Exec · Director · PromoterShiladitya Sengupta · Delhi, K7DirectorKrishna Gupta · Boston, MADirectorLu Huang · Newton, MADirectorFrancis Chen · Newton, MAExec · Director · PromoterChris Garabedian · Delanson, NYDirectorKumar Shiraigi · Delhi, K7DirectorMohanjit Jolly · San Francisco, CADirectorBhaskar Chaudhari · Delhi, K7DirectorAlab Rosling · Delhi, K7DirectorRyan Jones · Atlanta, GAExec · Director · PromoterJeffrey Muir · Atlanta, GADirectorChris Garabedian · Delanson, NYDirectorKumar Shiraigi · Delhi, K7DirectorKrishna Gupta · Boston, MADirectorMohanjit Jolly · Chicago, ILDirectorBhaskar Chaudhari · Delhi, K7DirectorAlab Rosling · Delhi, K7Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗